Literature DB >> 2114783

The hazards of using type 1C antiarrhythmic drugs for the treatment of paroxysmal atrial fibrillation.

F I Marcus1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2114783     DOI: 10.1016/0002-9149(90)90851-q

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  17 in total

1.  Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department.

Authors:  Y Kreiss; Y Sidi; H Gur
Journal:  Postgrad Med J       Date:  1999-05       Impact factor: 2.401

Review 2.  [Drug therapy of tachycardic atrial arrhythmias].

Authors:  D Wietholt; H Gülker
Journal:  Med Klin (Munich)       Date:  1997-04-15

Review 3.  [Current strategies in the treatment of atrial fibrillation].

Authors:  Imke Drewitz; Thomas Rostock; Boris Hoffmann; Daniel Steven; Helge Servatius; Thomas Meinertz; Stephan Willems
Journal:  Med Klin (Munich)       Date:  2008-11-15

Review 4.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

5.  Management of Atrial Fibrillation: Identifying and treating the causes.

Authors:  S W Rabkin
Journal:  Can Fam Physician       Date:  1991-03       Impact factor: 3.275

Review 6.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  The pharmacologic treatment of atrial fibrillation.

Authors:  R Bolognesi
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

8.  Antiarrhythmic drugs in the management of atrial fibrillation.

Authors:  J C Cowan
Journal:  Br Heart J       Date:  1993-10

Review 9.  Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmias.

Authors:  H M Bryson; K J Palmer; H D Langtry; A Fitton
Journal:  Drugs       Date:  1993-01       Impact factor: 9.546

Review 10.  Guidelines for the use of propafenone in treating supraventricular arrhythmias.

Authors:  A G Kishore; A J Camm
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.